Status:
TERMINATED
The Effects of Dexmedetomidine Dose on Motor Evoked Potentials
Lead Sponsor:
Hospital for Special Surgery, New York
Conditions:
Spinal Fusion
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
This a parallel group, two-arm, randomized superiority trial that will compare the effect of two different doses of dexmedetomidine on motor evoked potentials during spine surgery
Detailed Description
This a parallel group, two-arm, randomized superiority trial that will compare the effect of two different doses of dexmedetomidine on suitability of motor evoked potentials for intraoperative monitor...
Eligibility Criteria
Inclusion
- Patients undergoing multi-level posterior spine fusions requiring motor evoked potential monitoring
Exclusion
- Allergy to dexmedetomidine, propofol
- Conditions knows to make recording of motor evoked potentials difficult, including poorly controlled diabetes, severe peripheral neuropathy, severe myelopathy, or previous surgery during which motor evoked potentials were difficult to obtain
- Hepatic disease
Key Trial Info
Start Date :
November 28 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 17 2019
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT03378973
Start Date
November 28 2018
End Date
October 17 2019
Last Update
April 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Special Surgery
New York, New York, United States, 10021